Skip to content

Rival® RV8084Recalls & reported problems

Bard Peripheral Vascular, Inc. · Rival® PTA Balloon Dilatation Catheter 8 mm x 4 cm, 80 cm catheter · Class 2

All models of Rival (15)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741063893), received between Jul 12, 2017 and Jul 12, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Detachment of Device or Device Component1
  • Material Rupture1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 12, 2017Material Rupture; Detachment of Device or Device Component; Material Rupture; Detachment of Device or Device Component

    IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE IN THE CEPHALIC VEIN, THE PTA BALLOON ALLEGEDLY RUPTURED CIRCUMFERENTIALLY AT 20 ATM ON THE FIRST INFLATION. REPORTEDLY THE DISTAL PORTION OF THE PTA BALLOON WAS RETRIEVED SUCCESSFULLY. THE PTA BALLOON WAS EXCHANGED OVER THE GUIDEWIRE FOR ANOTHER THAT WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6709090 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page